Rein Therapeutics Inc. - RNTX Net earnings per one share for the last twelve months

Rein Therapeutics Inc. (RNTX) - corporate logo

High FDA barriers and patent protection for biologics create strong potential for Rein Therapeutics Inc (RNTX), as evidenced by the 12-month YoY EPS growth rates on the GURU.Markets chart, where the 40.40 indicator reflects the state of the metric. Risks are associated with a narrow specialization in tissue chemoprotection and a minimal headcount that relies on external contractors.

RNTX: aileronrx.com Net earnings per share for the last 12 months 02/11/2024 - 11/18/2026

Rein Therapeutics Inc - analytical breakdowns and key metrics (RNTX)

Fundamental company valuation:RNTX - Rein Therapeutics Inc.
Brand item of Aileron Therapeutics

This indicator measures the rate of change in net earnings per share over a rolling year, allowing investors to assess the fundamental profitability trend while filtering out market noise. By analyzing the EPS YoY TTM percentage dynamics, one can correlate the effectiveness of tissue protection drug development with financial results, where the stability of Rein Therapeutics Inc. (RNTX) is currently driven by progress in clinical trials.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Earnings per share for the last twelve months Mereo BioPharma Group (MREO)|Net earnings per share (EPS TTM) protalix.com (PLX)|Net earnings per share (EPS TTM) PLRX (Pliant Therapeutics Inc)|Net earnings per share (EPS TTM) Applied Therapeutics APLT|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)